Literature DB >> 21676636

PKU: high plasma phenylalanine concentrations are associated with increased prevalence of mood swings.

Karen Anjema1, Margreet van Rijn, Paul H Verkerk, Johannes G M Burgerhof, M Rebecca Heiner-Fokkema, Francjan J van Spronsen.   

Abstract

UNLABELLED: In phenylketonuria, knowledge about the relation between behavior and plasma phenylalanine is scarce. The aim of this study was to determine whether high phenylalanine is associated with disturbed behavior noticed by the patient and or close environment (parents or partners). 48 early treated PKU patients (median age 8.5, range 0-35 years) participated (median phenylalanine concentration in total sample 277 (range 89-1171) μmol/l; and in patients <12 years 238 (range 89-521) μmol/l). After sending blood samples, patients or close environment were interviewed with a standardized questionnaire whether they noticed hyperactivity, annoying behavior, mood swings and introvert or extravert behavior. The interviewer as well as the respondents were blinded with regard to the phenylalanine concentration.
RESULTS: Patients reported less deviant behavior compared to close environment. Mood swings were positively associated with phenylalanine concentrations in the total group (P=0.039) and patients <12 years (P=0.042). The relationships between temporary high phenylalanine concentrations and hyperactivity, annoying behavior, introvert and extravert behavior were not statistically significant.
CONCLUSION: there is a positive association between phenylalanine concentrations and mood swings. Copyright Â
© 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21676636     DOI: 10.1016/j.ymgme.2011.05.017

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  11 in total

Review 1.  Antioxidant treatment strategies for hyperphenylalaninemia.

Authors:  Priscila Nicolao Mazzola; George Albert Karikas; Kleopatra H Schulpis; Carlos Severo Dutra-Filho
Journal:  Metab Brain Dis       Date:  2013-05-09       Impact factor: 3.584

2.  Demographic and Psychosocial Influences on Treatment Adherence for Children and Adolescents with PKU: A Systematic Review.

Authors:  Emma Medford; Dougal Julian Hare; Anja Wittkowski
Journal:  JIMD Rep       Date:  2017-08-25

3.  Health-related quality of life in children and adolescents with phenylketonuria: unimpaired HRQoL in patients but feared school failure in parents.

Authors:  Eva Thimm; Lisa Elena Schmidt; Katrin Heldt; Ute Spiekerkoetter
Journal:  J Inherit Metab Dis       Date:  2013-01-08       Impact factor: 4.982

Review 4.  The complete European guidelines on phenylketonuria: diagnosis and treatment.

Authors:  A M J van Wegberg; A MacDonald; K Ahring; A Bélanger-Quintana; N Blau; A M Bosch; A Burlina; J Campistol; F Feillet; M Giżewska; S C Huijbregts; S Kearney; V Leuzzi; F Maillot; A C Muntau; M van Rijn; F Trefz; J H Walter; F J van Spronsen
Journal:  Orphanet J Rare Dis       Date:  2017-10-12       Impact factor: 4.123

5.  Social-cognitive functioning and social skills in patients with early treated phenylketonuria: a PKU-COBESO study.

Authors:  Rianne Jahja; Francjan J van Spronsen; Leo M J de Sonneville; Jaap J van der Meere; Annet M Bosch; Carla E M Hollak; M Estela Rubio-Gozalbo; Martijn C G J Brouwers; Floris C Hofstede; Maaike C de Vries; Mirian C H Janssen; Ans T van der Ploeg; Janneke G Langendonk; Stephan C J Huijbregts
Journal:  J Inherit Metab Dis       Date:  2016-02-25       Impact factor: 4.982

Review 6.  Systematic Review and Meta-Analysis of Neuropsychiatric Symptoms and Executive Functioning in Adults With Phenylketonuria.

Authors:  Deborah A Bilder; J Kay Noel; Erin R Baker; William Irish; Yinpu Chen; Markus J Merilainen; Suyash Prasad; Barbara J Winslow
Journal:  Dev Neuropsychol       Date:  2016-11-02       Impact factor: 2.253

7.  Acute exercise in treated phenylketonuria patients: Physical activity and biochemical response.

Authors:  Priscila Nicolao Mazzola; Bruno Costa Teixeira; Gabriel Henrique Schirmbeck; Alvaro Reischak-Oliveira; Terry G J Derks; Francjan J van Spronsen; Carlos Severo Dutra-Filho; Ida Vanessa Doederlein Schwartz
Journal:  Mol Genet Metab Rep       Date:  2015-10-22

8.  Long-Term Follow-Up of Cognition and Mental Health in Adult Phenylketonuria: A PKU-COBESO Study.

Authors:  Rianne Jahja; Francjan J van Spronsen; Leo M J de Sonneville; Jaap J van der Meere; Annet M Bosch; Carla E M Hollak; M Estela Rubio-Gozalbo; Martijn C G J Brouwers; Floris C Hofstede; Maaike C de Vries; Mirian C H Janssen; Ans T van der Ploeg; Janneke G Langendonk; Stephan C J Huijbregts
Journal:  Behav Genet       Date:  2017-08-03       Impact factor: 2.805

9.  When should social service referral be considered in phenylketonuria?

Authors:  Margreet van Rijn; Kirsten Ahring; Amaya Bélanger-Quintana; Kathi Dokoupil; Hulya Gokmen Ozel; Anna Maria Lammardo; Martine Robert; Júlio C Rocha; Anita MacDonald
Journal:  Mol Genet Metab Rep       Date:  2015-02-09

10.  Requirements for a minimum standard of care for phenylketonuria: the patients' perspective.

Authors:  Tobias S Hagedorn; Paul van Berkel; Gregor Hammerschmidt; Markéta Lhotáková; Rosalia Pasqual Saludes
Journal:  Orphanet J Rare Dis       Date:  2013-12-17       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.